Serum Uric Acid and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Two-Stage NHANES Study of MASLD Prevalence and All-Cause Mortality

Hafiz M. Ahmed, Umm e Aimen

Open source

DOI
10.1177/15578518261495389
Published
2026-10-08
Container
Metabolic Syndrome and Related Disorders
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/15578518261495389,
  title = {Serum Uric Acid and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Two-Stage NHANES Study of MASLD Prevalence and All-Cause Mortality},
  author = {Hafiz M. Ahmed and Umm e Aimen},
  year = {2026},
  journal = {Metabolic Syndrome and Related Disorders},
  doi = {10.1177/15578518261495389},
  url = {https://doi.org/10.1177/15578518261495389}
}

RIS

TY  - JOUR
TI  - Serum Uric Acid and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Two-Stage NHANES Study of MASLD Prevalence and All-Cause Mortality
AU  - Hafiz M. Ahmed
AU  - Umm e Aimen
PY  - 2026
JO  - Metabolic Syndrome and Related Disorders
DO  - 10.1177/15578518261495389
UR  - https://doi.org/10.1177/15578518261495389
ER  - 

APA

Ahmed, H. M., & Aimen, U. E. (2026). Serum Uric Acid and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Two-Stage NHANES Study of MASLD Prevalence and All-Cause Mortality. Metabolic Syndrome and Related Disorders. https://doi.org/10.1177/15578518261495389

Source records